Salute e Benessere
Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.
The next-generation sequencing (NGS) market is propelled by a confluence of factors, starting with a high degree of technological innovation, which includes ongoing advances in single-cell, long-read sequencing, and AI-driven data analysis, exemplified by product launches like Roche's SBX sequencing technology with Xpandomer chemistry in February 2025 , which enhances accuracy, speed, and clinical utility while reducing costs. This innovation is closely linked to product expansion, as companies continually launch new platforms, portable sequencers, and advanced bioinformatics tools to enhance workflow efficiency and meet diverse clinical and research needs. Furthermore, significant merger and acquisition (M&A) activity is fueling market growth and consolidation, allowing leading players to expand their technological capabilities and geographic reach; a notable example is Illumina's June 2025 agreement to acquire SomaLogic to improve its multi-omics capabilities. Crucial to broad adoption are regulatory frameworks which ensure the safety and efficacy of NGS-based assays, as increasing approvals from bodies like the FDA build confidence and facilitate integration into routine clinical practice. Finally, regional expansion into emerging markets across Asia-Pacific and Latin America is driving significant growth by leveraging improving healthcare infrastructure and government initiatives for genomic research, allowing companies to diversify their customer base and sustain long-term market growth worldwide.
Grand View Research has segmented the next-generation sequencing market based on technology, product, workflow, end use, and region:
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco , the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Explore – The world's most expansive market intelligence platform developed by Grand View Research. Gain insights from 30K+ Global & Regional Reports, 120K+ Country Reports, 1.2M+ Market Statistics, 200K+ Company Profiles, and 5 business solutions encompassing ESG and Sustainability Consulting, Procurement Intelligence, Pricing Index and Analysis, and Consumer Analytics.
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Blog - https://globalindustryherald.com/
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/next-generation-sequencing-ngs-market-poised-to-hit-42-25-billion-by-2033-key-drivers-behind-the-surge--latest-study-by-grand-view-research-inc-302614302.html